Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
p53 and related proteins in epithelial ovarian cancerP S Sengupta, A T McGown, V Bajaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancerM Zweifel, G C Jayson, N S Reed, et al.
British Journal of Cancer|March 6, 2003
Carcinosarcoma of the ovaryM A Harris, L M Delap, P S Sengupta, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|April 23, 2019
A novel discharge pathway for patients with advanced cancer requiring home parenteral nutritionA Bond, A Teubner, M Taylor, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2011
A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancerG Rustin, N Reed, G C Jayson, et al.
British Journal of Cancer|June 16, 2011
DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6J P B O'Connor, C J Rose, A Jackson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Stage- and CA125-related survival in patients with epithelial ovarian cancer treated at a cancer centerR E Board, C T P H Bruijns, A E Pronk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2010
Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapyC L Mitchell, J P B O'Connor, A Jackson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 13, 2016
Improved Survival from Ovarian Cancer in Patients Treated in Phase III Trial Active Cancer Centres in the UKL Khoja, K Nolan, R Mekki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2004
Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volumeG C Jayson, G J M Parker, S Mullamitha, et al.
Pageof 7